Jeisys Medical Inc. (KOSDAQ:A287410) announces a share repurchase program. Under the program, the company will repurchase up to KRW 10,000 million worth of its shares pursuant to a trust agreement with Samsung Securities Co., Ltd. The purpose behind the program is to stabilize the stock price and to enhance shareholder value. The program will continue until November 14, 2023.

As of May 14, 2023, the company had no shares in treasury through buyback within dividend capacity and had 131,048 shares in treasury through other acquisitions.